Autnami

Autnami combines Metformin Hydrochloride and Linagliptin for oral use, aiding blood sugar management. This dual-action medication supports glucose control in adults with type 2 diabetes.

Autnami is primarily used for managing type 2 diabetes by improving blood sugar levels. It combines two active ingredients: Metformin Hydrochloride, which reduces glucose production in the liver, and Linagliptin, which enhances insulin secretion. Together, they help regulate blood sugar levels in adults with this condition. Autnami is often prescribed as part of a broader diabetes management plan, including diet and exercise.

Common effects of Autnami may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when starting the medication. Some users may also experience headaches or dizziness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Autnami should be handled with care, especially for individuals with kidney issues or a history of pancreatitis. It is important to follow the prescribed dosage and monitor blood sugar levels regularly. Autnami should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Autnami may interact with certain medications, including other diabetes drugs, antibiotics, and some heart or blood pressure medications. Alcohol consumption should be limited, as it can affect blood sugar levels and increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking.